BioMarin Pharmaceutical Inc. (BMRN) Ownership

$55.43

south_east
-$0.14 (-0.25%)
Day's range
$55.01
Day's range
$56

BioMarin Pharmaceutical Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 11/12/2025 22.05 M $1.19 B   -8.15% 11.52%
VANGUARD GROUP INC 11/07/2025 18.58 M $1.01 B   -2.22% 9.71%
PRIMECAP MANAGEMENT CO/CA/ 11/12/2025 15.23 M $824.82 M   -3.44% 7.96%
DODGE & COX 11/13/2025 14.69 M $795.44 M   -2.79% 7.67%
STATE STREET CORP 11/14/2025 8.76 M $474.69 M   -0.94% 4.58%
VIKING GLOBAL INVESTORS LP 11/14/2025 8.32 M $450.73 M   -32.28% 4.35%
AQR CAPITAL MANAGEMENT LLC 11/14/2025 5.93 M $321.28 M   6.30% 3.10%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 3.54 M $191.29 M   1.95% 1.85%
MILLENNIUM MANAGEMENT LLC 11/14/2025 2.63 M $142.29 M   -7.31% 1.37%
CAPITAL RESEARCH GLOBAL INVESTORS 11/13/2025 2.54 M $137.44 M   547.55% 1.33%
GOLDMAN SACHS GROUP INC 11/14/2025 2.29 M $124.08 M   8.80% 1.20%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 2.25 M $121.60 M   42.68% 1.17%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 1.89 M $102.56 M   4.80% 0.99%
NORTHERN TRUST CORP 11/14/2025 1.66 M $90.03 M   0.43% 0.87%
UBS GROUP AG 11/13/2025 1.54 M $83.42 M   -9.17% 0.80%
MAN GROUP PLC 11/14/2025 1.49 M $80.88 M   1.11% 0.78%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 1.40 M $75.69 M   -10.19% 0.73%
SQUAREPOINT OPS LLC 11/14/2025 1.39 M $75.20 M   -16.98% 0.73%
MORGAN STANLEY 11/14/2025 1.38 M $74.76 M   -43.16% 0.72%
BANK OF NEW YORK MELLON CORP 11/03/2025 1.37 M $74.33 M   0.50% 0.72%
LOS ANGELES CAPITAL MANAGEMENT LLC 10/20/2025 1.33 M $72.16 M   378.95% 0.70%
DNB ASSET MANAGEMENT AS 11/12/2025 1.27 M $69.02 M   13.84% 0.67%
AMERIPRISE FINANCIAL INC 11/14/2025 1.23 M $66.54 M   -43.15% 0.64%
DEUTSCHE BANK AG\ 11/13/2025 1.09 M $58.82 M   22.29% 0.57%
UBS ASSET MANAGEMENT AMERICAS INC 11/14/2025 1.07 M $58.18 M   -18.61% 0.56%
RUSSELL INVESTMENTS GROUP, LTD. 11/13/2025 976.55 K $52.89 M   111.55% 0.51%
BANK OF AMERICA CORP /DE/ 11/14/2025 949.57 K $51.43 M   18.48% 0.50%
ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. 10/22/2025 935.47 K $50.66 M   45.78% 0.49%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 11/14/2025 913.16 K $49.46 M   43.29% 0.48%
LEGAL & GENERAL GROUP PLC 11/13/2025 909.58 K $49.26 M   -14.42% 0.48%
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC 11/13/2025 906.03 K $49.07 M   100.00% 0.47%
ABRDN PLC 11/07/2025 902.75 K $48.89 M   -8.17% 0.47%
FIRST TRUST ADVISORS LP 11/12/2025 894.96 K $48.47 M   21.19% 0.47%
FULLER & THALER ASSET MANAGEMENT, INC. 11/13/2025 890.42 K $48.23 M   -0.79% 0.47%
SOLEUS CAPITAL MANAGEMENT, L.P. 11/14/2025 890.30 K $48.22 M   -1.33% 0.47%
PICTET ASSET MANAGEMENT HOLDING SA 11/18/2025 890.21 K $48.18 M   -18.58% 0.47%
BARCLAYS PLC 11/12/2025 854.59 K $46.28 M   89.45% 0.45%
LSV ASSET MANAGEMENT 11/06/2025 845.50 K $45.79 M   2,445.46% 0.44%
VESTAL POINT CAPITAL, LP 11/14/2025 830.00 K $44.95 M   66.00% 0.43%
THRIVENT FINANCIAL FOR LUTHERANS 11/04/2025 778.11 K $42.14 M   8.42% 0.41%
PALO ALTO INVESTORS LP 11/14/2025 754.01 K $40.84 M   -10.29% 0.39%
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 10/17/2025 713.96 K $38.67 M   0.02% 0.37%
LOOMIS SAYLES & CO L P 11/13/2025 713.01 K $38.62 M   -1.90% 0.37%
AMUNDI 11/14/2025 712.89 K $39.64 M   25.59% 0.37%
NUVEEN, LLC 11/12/2025 706.27 K $38.25 M   -4.15% 0.37%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2025 693.89 K $37.58 M   31.81% 0.36%
EDMOND DE ROTHSCHILD HOLDING S.A. 11/13/2025 677.39 K $36.69 M   4.31% 0.35%
NOVO HOLDINGS A/S 11/14/2025 660.00 K $35.75 M   0.00% 0.34%
CANADA PENSION PLAN INVESTMENT BOARD 11/13/2025 637.20 K $34.51 M   17.72% 0.33%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 628.20 K $34.02 M   48.37% 0.33%

BioMarin Pharmaceutical Inc. institutional Ownership - FAQ's

During the previous two years, 912 institutional investors and hedge funds held shares of BioMarin Pharmaceutical Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 22.05 M

VANGUARD GROUP INC: 18.58 M

PRIMECAP MANAGEMENT CO/CA/: 15.23 M

DODGE & COX: 14.69 M

STATE STREET CORP: 8.76 M

VIKING GLOBAL INVESTORS LP: 8.32 M

93.66% of BioMarin Pharmaceutical Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 233.19 M shares in the last 24 months. This purchase volume represents approximately $12.93 B in transactions.